Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
MiracleCord
AddedFeb 18, 2024
UpdatedJun 18, 2026
MiracleCord

MiracleCord

MiracleCord, Inc.: Specializing in cord blood banking and private medical courier services since 1997.

HQ
Chicago, IL, US
Founded
1997
Overview
Compare
Fundraising
Employees
Website

MiracleCord, Inc. was founded in 1997 and is headquartered in Chicago, Illinois. The company specializes in providing cord blood banking services for families, offering a range of products including the StemCare thermal cord blood collection kit. MiracleCord also provides private medical courier services. Their core mission is to ensure the safe and efficient storage of cord blood, which can be used to treat various diseases, thereby contributing to advancements in medical treatments and family health security.

Notable affiliated people and investors are not specified, but the company has made significant strides in the cord blood banking industry. Key achievements include the development of the AXP II automated processing system and a $100,000 quality guarantee, underscoring their commitment to high standards and customer assurance. MiracleCord's impact is evident in its role in advancing stem cell research and providing families with critical medical options through reliable cord blood storage solutions.

MiracleCord - Similar Companies

MyCordBank.com logo

MyCordBank.com

mycordbank.com

Stemcyte logo

Stemcyte

stemcyte.com

StemSave logo

StemSave

stemsave.com

American CryoStem logo

American CryoStem

Stem Cell Reserve logo

Stem Cell Reserve

Cordis logo

Cordis

cordis.com

Next Healthcare logo

Next Healthcare

Stemedica Cell Technologies logo

Stemedica Cell Technologies

stemedica.com

Personalized Stem Cells logo

Personalized Stem Cells

Celltex Therapeutics logo

Celltex Therapeutics

celltexbank.com

Athersys logo

Athersys

ImmuneBridge logo

ImmuneBridge

immunebridge.com

AdiCyte logo

AdiCyte

Amnio Technology logo

Amnio Technology

Be The Match BioTherapies logo

Be The Match BioTherapies

MiracleCord - Quick Facts

Who are MiracleCord's competitors?

Companies similar to MiracleCord include MyCordBank.com, Stemcyte, StemSave and American CryoStem.

When was MiracleCord founded?

MiracleCord was founded in 1997.

Where is MiracleCord's headquarters located?

MiracleCord's headquarters is located in Chicago, IL, US.

When was MiracleCord's last funding round?

MiracleCord's most recent funding round was for $200k (USD) in February 2012.

How much has MiracleCord raised to-date?

As of Feb 9, 2012, MiracleCord has raised a total of $200k (USD).

How many employees does MiracleCord have?

MiracleCord has 2 employees as of Feb 5, 2024.

MiracleCord - Classification

Industry
  • Professional Service Companies
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Transactional
Customer
  • Consumers
Main Product
  • Cord Blood Banking
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 17 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 325000Chemical Manufacturing
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 325410Pharmaceutical and Medicine Manufacturing
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 2830Drugs
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8731Commercial Physical and Biological Research